Additional Paid in Capital of Quantumzyme Corp. from 31 Oct 2016 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary
Quantumzyme Corp. quarterly Additional Paid in Capital in USD history and change rate from 31 Oct 2016 to 31 Oct 2025.
  • Quantumzyme Corp. Additional Paid in Capital for the quarter ending 31 Oct 2025 was $5,195,456.
Source SEC data
View on sec.gov
Additional Paid in Capital, Quarterly (USD)
Additional Paid in Capital, YoY Quarterly Change (%)

Quantumzyme Corp. Quarterly Additional Paid in Capital (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,195,456 31 Oct 2025 10-Q 15 Dec 2025 2026 Q1
Q2 2025 $5,195,456 +$41,808 +0.81% 31 Jul 2025 10-Q 15 Dec 2025 2026 Q1
Q2 2024 $5,153,648 31 Jul 2024 10-K/A 17 Nov 2025 2025 FY
Q3 2016 $39,585 31 Oct 2016 10-Q 12 Dec 2016 2017 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.